- Investing Ideas
- /
- Hong Kong Pharmaceuticals & Biotech Sustainable Track Record
Hong Kong Pharmaceuticals & Biotech Sustainable Track Record
Results
3
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
3 companies
Consun Pharmaceutical Group
Market Cap: HK$7.8b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$9.36
7D
1.6%
1Y
63.1%
Uni-Bio Science Group
Market Cap: HK$400.1m
An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.
690
HK$0.067
7D
-2.9%
1Y
-22.1%
Shanghai Henlius Biotech
Market Cap: HK$15.5b
Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.
2696
HK$28.60
7D
-13.5%
1Y
93.8%